Alorabi, Mohamed

mohamed_alorabi@med.asu.edu.eg
Department of Clinical Oncology and Nuclear Medicine - Medicine
Internal ID: rp13218
Network Lab View Statistics Email Alert RSS Feed

Profile

images.jpeg picture
 
ORCID
 
Loading... 2 0 20 0 false
 
Full Name
Alorabi, Mohamed
 
Affiliation (Department)
 
Other emails
 
Scopus Author ID
 
WOS ID
 
Biography
I am a Consultant Clinical Oncologist and Lecturer of Clinical Oncology at the Faculty of Medicine, Ain Shams University, Cairo. I hold an MD and MSc in Clinical Oncology and am certified as a Consultant by the Saudi Commission for Health Specialties. I have successfully passed the ESMO Examination and am an ESCO Fellow of the European School of Oncology, reflecting formal recognition of advanced training in medical oncology at the European level.
My academic responsibilities include undergraduate and postgraduate teaching in clinical oncology, supervision of MSc and MD theses, participation in OSCE and clinical examinations, and leadership of journal clubs and case-based learning activities. I am actively involved in oncology education development and have contributed to organizing national and international scientific meetings and educational workshops in collaboration with European oncology societies.
I have served as a principal investigator and co-investigator in multinational and industry-sponsored clinical studies, including regional real-world research projects. I have authored more than 30 peer-reviewed publications in international journals and have presented my work at major global oncology conferences, including ASCO, ESMO, SABCS, and ICML.
I am an active member of several international oncology organizations, including ASCO, ESMO, the European School of Oncology, and the European Research Initiative on CLL. My academic work is driven by a strong commitment to advancing clinical oncology education, research excellence, and evidence-based cancer care within both local and international academic frameworks.

Publications

Results 1-15 of 15 (Search time: 0.0 seconds).

Issue DateTitleAuthor(s)
12015Use of angiotensin-converting enzyme inhibitors in the prophylaxis of anthracycline or trastuzumab-related cardiac dysfunction: preclinical and clinical considerationsAbdel-Rahman, Omar ; Alorabi, Mohamed 
2Mar-2016EGFR monoclonal antibodies in locally advanced head and neck squamous cell carcinoma: What is their current role?Alorabi, Mohamed ; Shonka, Nicole A; Ganti, Apar Kishor
31-Jul-2016Early stage non-small-cell lung cancer in octogenarian and older patients: A SEER database analysisGanti, Apar Kishor; Shostrom, Valerie; Alorabi, Mohamed ; Zhen, Weining; Marr, Alissa S.; Trujillo, Karin; Islam, K. M.Monirul; Lackner, Rudy P.; Kessinger, Anne
42020Prevalence, Associated Factors, and Consequences of Burnout Among Egyptian Physicians During COVID-19 PandemicAbdelhafiz, Ahmed Samir; Ali, Asmaa; Ziady, Hany H; Maaly, Ayman Mohamed; Alorabi, Mohamed ; Sultan, Eman A
5Oct-2020Knowledge, Perceptions, and Attitude of Egyptians Towards the Novel Coronavirus Disease (COVID-19)Abdelhafiz, Ahmed Samir; Mohammed, Zeinab; Ibrahim, Maha Emad; Ziady, Hany H; Alorabi, Mohamed ; Ayyad, Mohamed; Sultan, Eman A
62021Clinico-pathological relationship between androgen receptor and tumour infiltrating lymphocytes in triple negative breast cancerElghazawy, Hagar ; Bakkach, Joaira; Helal, Thanaa; Aref, Ahmed M; kelany, mohamed ; Abdallah, Lamiaa E; Abdelbakey, Fatma S; Aly, Dalia ; Ali, Doaa Z; Ahmed, Mai O; El-Hafeez, Amer Ali Abd; Ghosh, Pradipta; Alorabi, Mohamed 
72021Factors Influencing Participation in COVID-19 Clinical Trials: A Multi-National StudyAbdelhafiz, Ahmed Samir; Abd ElHafeez, Samar; Khalil, Mohammad Adnan; Shahrouri, Manal; Alosaim, Bandar; Salem, Raneem O; Alorabi, Mohamed ; Abdelgawad, Fatma; Ahram, Mamoun
81-Jan-2021Virtual educational meetings and activities during the COVID-19 pandemic and beyond: Egyptian oncologists' experienceAlorabi, Mohamed ; Abdelhafiz, Ahmed Samir; Mostafa, Nermen; Ali, Asmaa; Elghazawy, Hagar ; Mesbah, Ahmed; Jazieh, Abdul Rahman
9Dec-2021Predictors of poor precautionary practices towards COVID-19 among cancer patientsJazieh, Abdul R; Bensalem, Assia A; Bounedjar, Adda; Benbrahim, Zineb; Abusanad, Atlal M; Tashkandi, Emad M; Alnassar, Muath Ama; El Kinge, Abdul Rad; Al-Sukhun, Sana; Alsharm, Abdullah; Errihani, Hassan; Abdelhafiez, Nafisa A; Alkaiyat, Mohammad; Jradi, Hoda; Alorabi, Mohamed 
10May-2022Interpretation of P16 expression as a marker of HPV in colorectal cancerHafez, Fatma S; Meckawy, Ghada R; Alorabi, Mohamed ; Shakweer, Marwa M
1128-Nov-2024Analysis of four long non-coding RNAs for hepatocellular carcinoma screening and prognosis by the aid of machine learning techniquesAwad, Ahmed Samir Ahmed ; Abdeldaim, Amira; Mohammed, Ammar; Ali, Asmaa; Alorabi, Mohamed ; Hussein, Mariam M; Bakr, Yasser Mabrouk; Ibrahim, Asmaa Mohamed; Abdelhafiz, Ahmed Samir
122025Clinical presentation and treatment outcomes of gastric adenocarcinoma patients: a retrospective study from Ain Shams Clinical Oncology DepartmentEl-Bassiouny, Mohamed; El Khodary, Dalia Abd El Ghany; El Din, Mai Mohamed Ali Ezz; Elsayed, Alaa Mohamed Mohamed Ahmed; Reda, Christine; Alorabi, Mohamed 
133-Jan-2025Impact of adjuvant chemotherapy on survival in ypT0-2 N0 rectal cancerAlorabi, Mohamed Osama; Gouda, Abdelrahman; Yassmen Said Ahmed ; Abdelaal, Moamen; Eid, Reem; Yahia, Maha; Alorabi, Mohamed 
14Jul-2025A randomized comparative study on maintenance gemcitabine versus supportive care in pleural mesotheliomaKaram, Abanoub Samir; Abdelwahab, Sherif; Ezz El Din, Mai Mohamed Ali; Alorabi, Mohamed 
1511-Nov-2025Chronic lymphocytic leukaemia in the Middle East: a subgroup analysis from the CREEK study on treatment patterns and outcomesAbdelmoaty, Mohamed; Alshehri, Hassan; Alamoudi, Sameer; Buyukasik, Yahya; Abdelfattah, Rafaat; Alorabi, Mohamed ; Kamal, Amgad; Aboutaleb, Ahmed; Alhejazi, Ayman